LEF1 regulates breast cancer cell proliferation [72], and IGF2R enhances tumor cell invasion and migration [73] and serves as a poor prognostic marker in triple-negative breast cancer patients [74]. Here, IGF2R is linked to triple-negative breast carcinoma.